1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

BBI Solutions launches a fully validated human recombinant Cystatin C antigen

BBI Solutions (BBI), a world leader in purified human antigen manufacture has launched a fully validated recombinant Cystatin C to the IVD market.

 
PRLog - Aug. 27, 2014 - This week sees the launch of a new, fully validated recombinant Cystatin C antigen from BBI Solutions, which offers a host of benefits to its users:

·         Eliminates potential interferences from other proteins or contaminants due to high purity and low bioburden.

·         Demonstrates excellent recovery compared to native Cystatin C.

·         Ensures supply sustainability with a recombinant product, not dependent on a biological raw material.

Cystatin C is primarily used as a diagnostic marker for kidney function - routine kidney function tests measure serum Creatinine, Urea and glomular filtration rate (GFR). Serum Cystatin C is measured as part of the GFR test, as it is quicker and easier than traditional techniques of collecting urine samples over a 24 hour period. It has also been shown to not be affected by age, gender and body weight of the patient, making it the modern day diagnostic marker of choice.

This product is ideal for use in immunoassays, control and calibrator manufacture and in research and development. Full validation allows BBI to offer high reproducibility, excellent batch to batch consistency and long term supply, which can often prove troublesome with a native alternative.

Visit the BBI Solutions website (http://www.bbisolutions.com/products/2358-cystatin-c-reco...) to find out more about this product and to order online.

About

BBI Solutions is a leading manufacturer of raw materials and finished test platforms for the in-vitro diagnostic market. The BBI Group was founded in 1959, and has grown from a small specialist company to a global business with manufacturing sites spanning three countries.

Our range of raw materials includes human antigens, antibodies, serum and plasma products and clinical chemistry enzymes. We manufacture world renowned labels for lateral flow, ELISA assay and biosensors, including our gold nanoparticles and glucose oxidase.

BBI Solutions offer contract development and manufacturing services with a core focus on gold conjugation and lateral flow test manufacture.

BBI Solutions is part of the BBI Group.

Media Contact
Keli Stockbridge
***@bbisolutions.com

--- End ---

Click to Share

Contact Email:
***@bbisolutions.com
Source:BBI Solutions
Industry:Science
Tags:raw materials, ivd, immunoassay, diagnostic
Shortcut:prlog.org/12364218
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share